After a few sleepy quarters, Owens & Minor’s mid-year acquisition of Rotech Healthcare provided a jolt to the HME industry, but it’s hard to say what kind of downstream impact, if any, it could have on the overall appetite for M&A, say analysts. The deal, along with other favorable conditions, including improving interest rates, ongoing demand and even favorable reimbursement changes, like the 2023 passage of the Lymphedema Treatment Act, could trigger further activity among potential buyers not wanting to miss out on growth opportunities, say analysts.
Read the full article: Analysts Reflect on OMI Deal, HME Market Conditions //
Source: https://www.hmenews.com/article/analysts-reflect-on-omi-deal-market-conditions